Erratum to: Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial (Q59822556)
Jump to navigation
Jump to search
scholarly article published in BMC Medicine
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Erratum to: Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial |
scholarly article published in BMC Medicine |
Statements
Erratum to: Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial (English)
0 references
2 September 2013
0 references
11
0 references
1
0 references